Table 1. Summary of the causal relationship between multistep tumorigenesis and glycomic alterations.
Observed phenomena | TERT | SV40ER | H-RasV12 | MyrAKT | (Possible) Causal gene(s) |
---|---|---|---|---|---|
Total N-glycans | ↑ | ↓↓ | → | → | various |
Pauci-mannose type N-glycans | ↑↑ | ↓↓ | ↑ | ↓ | unidentified |
N-glycans with multiple fucose | → | ↑↑ | ↓↓ | ↑ | various FUTs |
N-glycans with bisect GlcNAc | → | → | ↑↑↑ | ↓↓↓ | MGAT3 |
N-glycans with β1–6 linked GlcNAc | ↑ | ↓ | → | ↓ | MGAT5 |
N-glycans with β1–6 linked GlcNAc (relative abundance in total C/H glycans) | → | ↑ | → | → | MGAT5 etc |
N-glycans with monoantennary glycans | ↑↑ | ↓↓↓ | ↑ | → | MGAT2 |
Proportion of α2,6 sialic acids of total sialic acids in A1 and A2 | ↓ | → | ↑ | ↓ | ST6GAL I, II, ST3GAL III, IV |
Proportion of α2,6 sialic acids of total sialic acids in A1F and A2F | ↓↓ | ↓↓↓ | ↑↑↑ | ↓↓↓ | ST6GAL I, II, ST3GAL III, IV |
N-glycans with Neu5Gc (%) | ↑↑↑ | ↑ | ↑ | ↓ | lysosomal sialic acid transporter/ lysosomal sialidase |
Total neutral O-glycans | ↓↓ | ↑↑ | ↓↓ | ↑ | various SIATs |
Disialylated O-glycans (mostly disialyl T) | ↓ | ↓↓ | ↑↑ | ↓ | ST6GALNAC |
O-glycans with core2 | ↓ | → | ↓↓↓ | ↑↑ | B3GNT3 or GCNT1, 3, 4 |
O-glycans with Neu5Gc | → | ↑↑↑ | → | → | lysosomal sialic acid transporter/ lysosomal sialidase |
Total GSL glycans | → | ↓↓ | ↓ | ↑↑ | various |
LacCer | ↑↑↑ | ↓↓↓ | ↑↑↑ | ↓↓ | UGCG/B4GALT6 |
Total ganglio-series GSL glycans | → | ↓↓ | ↓↓↓ | ↑ | balance of ST3GAL5, B4GALNT1, A4GALT and B3GNT5 |
GM3 | ↓ | → | ↓↓ | ↑ | ST3GAL5 |
GM2 | ↓ | ↓ | ↓↓↓ | ↑ | B4GALNT1 |
GM1 | → | ↓↓ | ↓↓ | → | B3GALT4 |
GD3 | ↑↑↑ | ↓↓↓ | ↑ | → | SIAT8A |
GD1 | ↑ | ↓↓ | ↓↓↓ | ↑↑ | B3GALT4 |
Total globo-series GSL glycans | ↓ | ↑↑↑ | ↑↑ | ↑↑ | balance of ST3GAL5, B4GALNT1, A4GALT and B3GNT5 |
Gb3 | ↑↑↑ | ↑↑↑ | ↑↑ | ↑ | A4GAT |
Gb4 | ↓↓ | ↑↑↑ | ↑↑ | ↑ | B3GALNT1 |
SSEA-4 | → | ↓ | ↑↑↑ | ↓ | ST8SIA1 |
Galβ1-4GlcNAcβ1-6(Galβ1–3)GalNAcβ1-3Galα1-4Galβ1-4Glc | → | ↑↑↑ | ↑↑↑ | ↓↓↓ | GNTs and GALTs |
Total lacto-series GSL glycans | → | ↓↓ | → | ↑↑↑ | balance of ST3GAL5, B4GALNT1, A4GALT and B3GNT5 |
Lc-series glycans with fucose | ↓↓↓ | ↑↑↑ | ↓↓ | ↑↑↑ | various FUTs |
Galα1-3Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glc | → | ↓↓ | ↑↑↑ | ↓↓ | GNTs and GALTs |
GSL glycans with sialic acid(s) | → | ↓↓ | ↓↓ | ↑↑↑ | various SIATs |
GSL glycans with Neu5Gc | → | ↑↑ | ↑ | → | balance of ST3GAL5, B4GALNT1, A4GALT and B3GNT5 |
Increase by 1.25–2-fold (↑), 2–5-fold (↑↑), and > 5-fold (↑↑↑). Decrease by 0.5–0.75-fold (↓), 0.2–0.5-fold (↓↓), and < 0.2-fold (↓↓↓). The increase and decrease is within 0.75-fold and 1.25-fold (→)